Original language | English (US) |
---|---|
Pages (from-to) | 535-538 |
Number of pages | 4 |
Journal | The Lancet |
Volume | 400 |
Issue number | 10351 |
DOIs | |
State | Published - Aug 13 2022 |
ASJC Scopus subject areas
- General Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: The Lancet, Vol. 400, No. 10351, 13.08.2022, p. 535-538.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
AU - Mello, Michelle M.
AU - Opel, Douglas J.
AU - Benjamin, Regina M.
AU - Callaghan, Timothy
AU - DiResta, Renee
AU - Elharake, Jad A.
AU - Flowers, Lisa C.
AU - Galvani, Alison P.
AU - Salmon, Daniel A.
AU - Schwartz, Jason L.
AU - Brewer, Noel T.
AU - Buttenheim, Alison M.
AU - Carpiano, Richard M.
AU - Clinton, Chelsea
AU - Hotez, Peter J.
AU - Lakshmanan, Rekha
AU - Maldonado, Yvonne A.
AU - Omer, Saad B.
AU - Sharfstein, Joshua M.
AU - Caplan, Arthur
N1 - Funding Information: PJH is a developer of a COVID-19 vaccine construct, which was licensed by Baylor College of Medicine to Biological E, a commercial vaccine manufacturer for scale-up, production, testing, and licensure. NTB reports personal fees from WHO, US national Centers for Disease Control and Prevention, and Merck outside the submitted work. RMC received research grant funding from Novo Nordisk Foundation, outside the submitted work. RL reports grants from Pfizer, GlaxoSmithKline, Sanofi Pasteur, and Merck, and personal fees from BIO and the Infectious Disease Prevention Network, outside the submitted work. YAM is a member of a data safety monitoring board for Pfizer and a site Principal Investigator for a Pfizer vaccine trial, outside the submitted work. MMM reports personal fees from law firms representing retail pharmacies and generic drug companies that have sued other drug companies for antitrust law violations, outside the submitted work, and served as an advisor to Verily Life Sciences on an app designed to facilitate safe return to work and school during the COVID-19 epidemic. DJO reports grants from the US National Institutes of Health, outside the submitted work. DAS reports grants from Merck and personal fees from Pfizer and Janssen, outside the submitted work. The other authors declare no competing interests.
PY - 2022/8/13
Y1 - 2022/8/13
UR - http://www.scopus.com/inward/record.url?scp=85135916102&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135916102&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(22)00875-3
DO - 10.1016/S0140-6736(22)00875-3
M3 - Review article
C2 - 35817078
AN - SCOPUS:85135916102
SN - 0140-6736
VL - 400
SP - 535
EP - 538
JO - The Lancet
JF - The Lancet
IS - 10351
ER -